Connection

James Ballenger to Alprazolam

This is a "connection" page, showing publications James Ballenger has written about Alprazolam.
Connection Strength

1.081
  1. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
    View in: PubMed
    Score: 0.210
  2. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993 Oct; 54 Suppl:15-21; discussion 22-4.
    View in: PubMed
    Score: 0.109
  3. Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia. Br J Psychiatry. 1993 Jun; 162:788-9; discussion 790-4.
    View in: PubMed
    Score: 0.106
  4. Effect of alprazolam on depression in panic disorder. J Clin Psychopharmacol. 1991 Apr; 11(2):145-6.
    View in: PubMed
    Score: 0.091
  5. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry. 1988 May; 45(5):413-22.
    View in: PubMed
    Score: 0.075
  6. Alprazolam in the treatment of social phobia. J Clin Psychiatry. 1988 Jan; 49(1):17-9.
    View in: PubMed
    Score: 0.073
  7. Sexual side effects of alprazolam. Am J Psychiatry. 1987 Feb; 144(2):254-5.
    View in: PubMed
    Score: 0.068
  8. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry. 1997; 58 Suppl 11:11-8.
    View in: PubMed
    Score: 0.034
  9. Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial. Psychopharmacol Bull. 1996; 32(1):149-55.
    View in: PubMed
    Score: 0.032
  10. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry. 1995 Oct; 167(4):487-94.
    View in: PubMed
    Score: 0.031
  11. Predictors of response to alprazolam and placebo in patients with panic disorder. J Affect Disord. 1994 Jan; 30(1):5-13.
    View in: PubMed
    Score: 0.028
  12. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry. 1992 Nov; 149(11):1556-62.
    View in: PubMed
    Score: 0.025
  13. Discontinuation of alprazolam after long-term treatment of panic-related disorders. J Clin Psychopharmacol. 1992 Oct; 12(5):352-4.
    View in: PubMed
    Score: 0.025
  14. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. J Clin Psychopharmacol. 1992 Apr; 12(2):96-103.
    View in: PubMed
    Score: 0.024
  15. Efficacy of benzodiazepines in panic disorder and agoraphobia. J Psychiatr Res. 1990; 24 Suppl 2:15-25.
    View in: PubMed
    Score: 0.021
  16. Sequence of improvement in agoraphobia with panic attacks. J Psychiatr Res. 1990; 24(1):1-8.
    View in: PubMed
    Score: 0.021
  17. Three cases of panic disorder with agoraphobia in children. Am J Psychiatry. 1989 Jul; 146(7):922-4.
    View in: PubMed
    Score: 0.020
  18. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord. 1989 Jan-Feb; 16(1):49-58.
    View in: PubMed
    Score: 0.020
  19. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry. 1988 May; 45(5):423-8.
    View in: PubMed
    Score: 0.019
  20. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry. 1987 May; 144(5):664-5.
    View in: PubMed
    Score: 0.017
  21. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry. 1986 Sep; 47(9):470-3.
    View in: PubMed
    Score: 0.017
  22. Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.